
==== Front
Aging Clin Exp Res
Aging Clin Exp Res
Aging Clinical and Experimental Research
1594-0667
1720-8319
Springer International Publishing Cham

39172202
2812
10.1007/s40520-024-02812-9
Review
Causal factors for osteoarthritis risk revealed by mendelian randomization analysis
Luo Qingfeng 123
Zhang Shiyong 4
Yang Qiyuan 123
Deng Yuyi 123
Yi Hengjing 23
Li Xingsheng ptlxs@163.com

23
1 https://ror.org/017z00e58 grid.203458.8 0000 0000 8653 0555 State Key Laboratory of Ultrasound in Medicine and Engineering, Chongqing Medical University, Chongqing, 400016 China
2 https://ror.org/00r67fz39 grid.412461.4 Chongqing Key Laboratory of Ultrasound Molecular Imaging, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010 China
3 https://ror.org/00r67fz39 grid.412461.4 Department of Geriatrics, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010 China
4 grid.12981.33 0000 0001 2360 039X Department of Joint Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080 Guangdong China
22 8 2024
22 8 2024
2024
36 1 17629 4 2024
15 7 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Osteoarthritis (OA), a prevalent chronic disease among the elderly, presents a complex pathogenesis and currently lacks effective treatment. Traditional observational studies are time-consuming, labor-intensive, susceptible to confounding factors, and cannot establish causal relationships. Mendelian randomization (MR) analysis, leveraging genetic variation to assess causal associations between exposures and outcomes, offers a cost-effective and efficient alternative. Over the past decade, large-scale genome-wide association studies have identified numerous genetic variants linked to OA risk factors, facilitating MR study design. In this review, we systematically identified 52 MR studies meeting specific criteria and evaluated their quality, exploring the impact of lifestyle, nutrition, comorbidities, circulating metabolites, plasma proteins, and other health factors on OA risk. We discuss the results and potential mechanisms of MR findings, addressing conflicting evidence based on existing literature and our prior research. With the ongoing expansion of genome-wide association data, we anticipate MR’s role in future OA studies to broaden, particularly in drug development research using targeted MR approaches. We thus aim for this paper to offer valuable insights for researchers and clinicians in related fields.

Supplementary Information

The online version contains supplementary material available at 10.1007/s40520-024-02812-9.

Keywords

Osteoarthritis
Mendelian randomization
Causality
Genetics
the Program for Youth Innovation in Future Medicine, Chongqing Medical Universityno.w0155 the Natural Science Foundation of Chongqingno. 2023NSCQ-MSX0742 issue-copyright-statement© Springer Nature Switzerland AG 2024
==== Body
pmcIntroduction

Osteoarthritis (OA) is a common degenerative disease that primarily affects the elderly [1]. The pain and joint deformities associated with OA are significant contributors to disability and diminished quality of life in this age group [2]. The prevalence of osteoarthritis is increasing annually and is expected to increase by at least 50% overall by 2050 [3]. This has led to a significant rise in the costs associated with treatment and rehabilitation, posing a substantial public health burden and challenge [4–7]. Bone degeneration is a multifaceted process primarily influenced by genetic and environmental factors [8, 9]. Observational studies offer unparalleled advantages in conducting extensive epidemiological investigations and exploring causes. Nevertheless, in conventional observational analyses, it is challenging to fully address confounding factors [10]. Simultaneously, definitive proof of causal relationships between exposure factors and diseases remains elusive [11]. Findings on osteoarthritis in traditional observational studies are often disputed or conflicting, mainly due to ethical constraints and technical challenges. As a result, investigating the pathogenic factors and treatment strategies for osteoarthritis through Mendelian randomization (MR) analyses has emerged as a viable approach.

MR analysis is an observational study that uses genetic variation to make inferences about potential causal relationships between exposures (risk factors) and phenotypes [12, 13]. The genetic variants associated to exposure are randomly assigned at conception and are not influenced by factors such as acquired lifestyle [14]. Researchers consider MR to be akin to an observational randomized controlled trial, as it helps mitigate confounding factors and allows for the inference of causal associations found in observational studies [15]. Over the past 20 years, MR analyses have significantly advanced, expanding to investigate a wide range of topics. Initially focused on exploring risk factors for disease, these analyses now encompass studies on drug mechanisms of action and other relevant areas [14, 16, 17]. MR analysis mitigates ethical concerns by utilizing publicly available genetic variant data. These genetic variants are linked to exposure factors but remain unaffected by lifestyle or socioeconomic variables. The technical validity of Mendelian randomization studies has been extensively demonstrated across various degenerative conditions such as Alzheimer’s disease [18], Parkinson’s disease [19], and OA [20].

The core assumptions of MR include the relevance assumption, meaning the genetic variants selected must have a strong association with the exposure; the independence assumption, meaning the genetic variants are not influenced by any measured or unmeasured confounders; and the exclusion restriction assumption, meaning the selected genetic variants can only affect the outcome through the exposure pathway (Fig. 1). In order for causal inferences between exposure and outcome to be valid, all three assumptions must be fully satisfied [21, 22]. The main methods used in MR analyses include single-sample MR analysis and two-sample MR analysis [23]. In single-sample MR, both exposure- and outcome-related genetic variants come from the same sample, allowing for the assessment of causality within a single population. On the other hand, two-sample MR analysis utilizes genetic variants for exposure and outcome from separate independent populations, which can increase the statistical efficacy of the method by utilizing existing pooled data from large-scale GWAS consortia [24, 25]. Various large biological databases currently offer genetic variation data, including the UK Biobank, which can support single-sample or two-sample MR analyses effectively. Moreover, a growing number of disease GWAS studies are enriching genetic data for multi-ethnic and multi-population MR analyses, significantly boosting both the quantity and quality of current MR studies [25, 26].

Fig. 1 Basic principles and core assumptions of Mendelian randomization (MR). The relevance assumption asserts that genetic variation is strongly correlated with exposure. The independence assumption indicates that genetic variation is independent of potential confounding factors. Lastly, the exclusion restriction assumption proposes that genetic variation influences the outcome solely through its effect on exposure

As in all specialties, exploring disease risk factors is necessary but often costly. MR analysis serves as a cost-effective and reliable research method that has significantly contributed to the body of evidence in OA research. Nevertheless, the number of risk factors for OA uncovered by MR is rapidly increasing, and certain causal associations appear to contradict available evidence, thereby complicating result interpretation. This review provides a comprehensive summary of MR studies related to OA published to date. A thorough search on PubMed (through December 2023), using specific keywords such as ‘Mendelian randomization,’ ‘osteoarthritis,’ ‘degenerative osteoarthropathy,’ and ‘OA,’ was conducted to identify relevant studies. The analysis encompasses a review of published reports on MR analyses in OA diseases, highlighting research progress and the challenges encountered.

Results

Description of included studies

After applying several inclusion criteria, a total of 52 studies were included in this review (Fig. 2) [27–78]. Since there are no standardized quality assessment criteria, we followed the approach of several previous reviews and assessed the quality of these studies by examining their hypothesis validation [79, 80] (etable 1–3). Additionally, we summarized the main findings of these studies and indicated the source of SNPs for each study (etable 4). With a few exceptions, most studies used data from the UK Biobank, the largest human genetic database to date. Thus, MR studies of OA risk have been conducted mainly using genetic information from European populations. Factors revealed by MR to be associated with OA risk mainly include lifestyle, nutrition, comorbidities, circulating metabolites, plasma proteins, and other health factors. In several studies, OA has also been found to have a causal effect on other diseases when considered as an exposure factor. These associations were mainly found in reverse causality analyses of comorbidity MR studies, and we believe that these factors are also noteworthy for OA risk.

Fig. 2 Literature screening process diagram

Lifestyle and nutritional factors

The occurrence and development of osteoarthritis are influenced by both genetic and environmental factors [8, 9]. Numerous studies have highlighted the increasing incidence of osteoarthritis, which is closely linked to modern lifestyle changes [81](Table 1). Ni et al. reported a potential causal association between sleep and osteoarthritis, suggesting that insomnia or short sleep duration may increase the risk of osteoarthritis [27]. This finding is consistent with previous cross-sectional and case-control studies [82, 83], despite an incomplete understanding of the underlying biological mechanisms. Animal studies have reported that sleep deprivation can induce a cytokine storm-like syndrome in mammals, significantly weakening the body’s immunity [84]. Another perspective suggests that insufficient melatonin secretion due to sleep disorders may be a potential mechanism for these associations [85]. Melatonin is believed to affect OA by regulating proinflammatory factors, cartilage-degrading enzymes, and other inflammatory mediators [86]. Nevertheless, these insights currently lack validation in populations. Future exploration in large prospective cohorts will help identify these causal relationships and potential mechanisms.

The impact of exercise on osteoarthritis has been a topic of debate. Upon analyzing different exercise intensities, it was discovered that varying levels of exercise intensity had contrasting effects on osteoarthritis risk. Low-intensity exercise, as predicted genetically, was found to be associated with a higher risk of osteoarthritis [30], while moderate-intensity activities (such as housework and brisk walking) were associated with a reduced risk [28, 29]. In contrast to multiple intensities of exercise, a completely inactive lifestyle, such as sedentary behavior and prolonged television viewing, can significantly increase the risk of all osteoarthritis [31]. Although MR analysis revealed multiple causal associations between exercise and OA, observational studies remain skeptical of these associations [87], suggesting that the underlying mechanisms may be complex and unclear for a long time.

The debate surrounding the dietary impact of coffee and tea remains contentious. Various observational studies have highlighted a potential link between coffee and tea consumption and a lower risk of certain diseases, such as cancer, cardiovascular disease, and osteoarthritis [88–90]. However, a recent Mendelian randomization (MR) study suggested a possible association between genetically predicted coffee intake and a heightened risk of osteoarthritis [32], while tea consumption was found to significantly elevate the overall risk of osteoarthritis [33]. Such contradictory results may arise from study design, where observational studies are more likely to have biases. For example, our previous work found a dose-dependent, nonlinear association between coffee and tea consumption and bone health, and this association differed significantly by gender, coffee type, and other subgroups [91]. For these causal associations revealed by MR, some studies have reported that caffeine, the main active substance in coffee and tea, and its metabolites in vivo can directly influence the anabolic actions of chondrocytes [92, 93]. Moreover, it has been proposed that caffeine intake is associated with the inflammatory cytokines IL-1 and TNF-α [94]. Furthermore, consistent findings indicated that smoking and alcohol consumption were more prominently linked to an increased risk of osteoarthritis, with both behaviors significantly raising the risk across all types of osteoarthritis [34, 35].

Table 1 Evidence from MR studies on lifestyle and osteoarthritis risk

lifestyle	causal direction	Osteoarthritis	OR	years	Resources	
Insomnia	→	Overall OA	1.22	2022	Ni [27].	
Short sleep duration	→	Overall OA	1.04		Ni [27].	
Housework	→	Overall OA	0.32	2023	Li [28].	
	→	Knee OA	0.26			
Walking for pleasure	→	Overall OA	0.87		Li [28].	
	→	Knee OA	0.14			
Walking pace	→	Overall OA	0.11	2023	Qiu [29].	
	→	Knee OA	0.17			
	→	Hip OA	0.24			
leisure screen time	→	Overall OA	1.31	2023	Wang [30].	
	→	Knee OA	1.44			
	→	Hip OA	1.13			
Sedentary behavior	→	Overall OA	1.80/1.98	2023	Cao [31]. /Li [28].	
	→	Knee OA	1.85/1.64			
	→	Hip OA	1.65/1.32			
Coffee	→	Overall OA	1.01	2021	Zhang [32].	
	→	Knee OA	1.02			
Tea	→	Overall OA	1.19	2022	Li [33].	
Alcohol	→	Overall OA	1.33	2023	Wen [34].	
Smoking	→	Overall OA	1.61	2022	Ni [35].	
	→	Knee OA	1.54			
	→	Hip OA	1.62			

Comorbidities

Comorbidities play a crucial role in predicting the onset and prognosis of osteoarthritis in research [95]. Observational studies have shown that the majority of osteoarthritis patients have at least one comorbid disease, often related to the cardiovascular and digestive systems [96, 97]. Recent MR studies have identified causal links between osteoarthritis and various comorbidities, although some studies present conflicting evidence. For example, several studies by Zhao et al. noted a causal association between genetically predicted risk of osteoarthritis and an increased risk of stroke [36–38], while Cai et al. suggested a causal association between ischemic stroke and osteoarthritis [39]. Additionally, Cai et al. identified a positive causal relationship between genetically predicted osteoarthritis and Parkinson’s disease [39]. Furthermore, regarding cardiovascular disease, the current MR evidence is contradictory. Wang et al. reported conflicting evidence, with hip osteoarthritis linked to an increased risk of heart failure, while coronary artery disease appeared to have a protective effect on knee osteoarthritis risk [37]. Xu et al. noted a causal association between myocardial infarction and reduced osteoarthritis risk [40]. Yin et al. highlighted a causal effect of osteoarthritis on atrial fibrillation risk but a protective effect against coronary atherosclerosis [41]. Other studies have shown that genetically determined osteoporosis may reduce osteoarthritis risk [42], while osteoarthritis could increase the risk of type 2 diabetes [44], gastroesophageal reflux disease [45], and bladder cancer [46], but no inverse association was found [43]. Moreover, allergic diseases like allergic rhinitis and asthma have been genetically linked to an increased risk of osteoarthritis [47](Table 2).

It is worth noting that caution should be exercised in interpreting causal associations between osteoarthritis and comorbidities. Some studies have suggested that the association between OA and the risk of cardiovascular disease can be explained by changes in the amount of exercise, but this view is not widely supported [98, 99]. In addition to potential confounders and study quality [45], co-inheritance, on the other hand, may explain some of the causal associations between diseases [100]. Although more mechanistic research evidence is needed to validate the association between osteoarthritis and comorbidities, this suggestive MR evidence could provide new directions for osteoarthritis research and consider more comorbidities in diagnosis and treatment.

Table 2 Evidence from MR studies on comorbidities and osteoarthritis risk

Comorbidities	Causal direction	Osteoarthritis (OA)	OR	Years	Resources	
Stroke	←	Overall OA	1.12	2022	Zhao [36].	
	←	Hip OA	1.14	2022	Wang [37].	
Lacunar stroke	←	Hip OA	1.20	2022	Shen [38].	
Ischemic stroke	→	Overall OA	1.03	2021	Cai [39].	
Parkinson’s disease	←	Overall OA	1.19		Cai [39].	
Heart failure	←	Hip OA	1.07	2022	Wang [37].	
Coronary heart disease	→	Knee OA	0.90		Wang [37].	
Myocardial infarction	→	Overall OA	0.95	2022	Xu [40].	
Atrial fibrillation	←	Overall OA	1.11	2023	Yin [41].	
Coronary Atherosclerosis	←

→

	Overall OA	0.88

0.95

		Yin [41].	
Osteoporosis	→	Overall OA	0.75	2022	Liu [42].	
Type 2 diabetes	→	Overall OA	—	2020	Cui [43].	
Type 2 diabetes	←	Knee OA	1.18	2023	Xing [44].	
Gastroesophageal Reflux disease	←	Overall OA	1.26	2023	Xu [45].	
Bladder cancer	←	Overall OA	1.07	2023	Zhang [46].	
Allergic disease	→	Knee OA	1.07	2023	Baker [47].	
Allergic rhinitis	→	Knee OA	1.07		Baker [47].	
Asthma	→	Overall OA	1.02		Baker [47].	
	→	Knee OA	1.04			

Circulating metabolites and proteins

Osteoarthritis is a multifaceted process involving metabolism, nutrition, and inflammation [101–103].While traditional observational studies have examined various peripheral biomarkers and established their potential link to the risk of osteoarthritis, most of these markers are assessed at specific time points in both cross-sectional and cohort studies. This makes it challenging to determine the association between longitudinal trends over time and osteoarthritis. Consequently, there has been a growing interest in MR studies in recent years, which aim to investigate the causal relationship between genetically predicted levels of peripheral markers and the risk of osteoarthritis.

The role of metabolism in the progression of bone and joint health has been extensively studied, with abnormal metabolites potentially acting as predictive markers for osteoarthritis and even exacerbating the disease [101, 104]. Recent advancements in large-scale next-generation sequencer technology and GWAS analysis have facilitated the study of metabolism-related Mendelian randomization analysis. Through 11 MR studies, causal relationships between thousands of metabolites and the risk of osteoarthritis have been investigated [48–58](Table 3). Eleven metabolites were found to have a causal association with an increased risk of osteoarthritis, including isovaleryl carnitine, taurocholate, kynurenine, acetaminophen 4-sulfate, homocysteine, serum iron, transferrin saturation, insulin-like growth factor-1, serum copper, and serum zinc. On the other hand, 10 metabolites were associated with a reduced risk of osteoarthritis, such as 1-linolenoylglycerophosphorylcholine, arginine, alanine (Ala), omega-3 fatty acids, omega-6 fatty acids, LDL cholesterol, transferrin, folate, vitamin B12, and serum calcium. Potential mechanistic explanations include direct effects of metabolites on chondrocytes, or altering the inflammatory state, which in turn affects the metabolic activity of cartilage. For example, nitric oxide, a metabolite produced in vivo from arginine, has strong antioxidant and anti-inflammatory effects, and oxidative stress has been widely implicated in the progression of OA [105, 106]. In contrast, kynurenine, a major degradation product of tryptophan, inhibits chondrocyte cell proliferation in a dose-dependent manner [107]. Furthermore, activation of the kynurenine-aromatic hydrocarbon receptor axis impairs chondrogenesis and chondroprotection in mesenchymal stromal cells [108]. Similarly, one of the components of Omega-6 fatty acids, arachidonic acid (AA), has been identified as a precursor to a variety of potent pro-inflammatory mediators. Consequently, Omega-6 fatty acid levels are significantly correlated with chronic inflammation in the body [109, 110].

Although a number of other metabolites have been found to be causally related to OA, the underlying mechanisms remain unclear. For instance, two separate MR studies have shown a link between increased LDL cholesterol levels and a reduced risk of osteoarthritis, contradicting previous observational studies [52, 53]. It has been suggested that LDL can reduce APOA1 levels and serum amyloid A protein in human primary chondrocytes and fibroblast-like synoviocytes, thereby alleviating joint inflammation [111]. However, we remain cautious about this hypothesis. While the specific mechanisms of action of these metabolites on osteoarthritis were not determined by the researchers, their findings offer valuable insights for future studies.

Table 3 Evidence from MR studies on metabolism-related molecules and osteoarthritis risk

Metabolism-related molecules	Causal direction	Osteoarthritis (OA)	OR	Years	Resources	
1-linoleoylglycerophosphocholine	→	Hand/Finger OA	0.36/0.21	2023	Gu [48].	
Isovalerylcarnitine	→	Hand OA	1.51		Gu [48].	
Taurocholate	→	Thumb OA	1.35		Gu [48].	
Kynurenine	→	Hip/Knee OA	1.44		Gu [48].	
Arginine	→	Hip OA	0.56		Gu [48].	
4-acetaminophen sulfate	→	Hip OA	1.02		Gu [48].	
Alanine(Ala)	→	Hip/Knee OA	0.82	2023	Cui [49].	
Homocysteine	→	Overall OA	1.10	2023	Hong [50].	
	→	Knee OA	1.08		Hong [50].	
	→	Hip OA	1.08		Hong [50].	
Omega−3 fatty acids	→	Knee OA	0.94	2023	Li [51].	
Omega−6 fatty acids	→	Knee OA	0.93		Li [51].	
	→	Hip OA	0.89		Li [51].	
Low-density lipoprotein cholesterol(LDL)	→	Overall OA	0.87	2019	Hindy [52].	
Low-density lipoprotein cholesterol(LDL)	→	Hip/Knee OA	0.90	2022	Meng [53].	
Apolipoprotein B(APOB)	→	Hip/Knee OA	0.93		Meng [53].	
	→	Hip OA	0.89		Meng [53].	
	→	Knee OA	0.93		Meng [53].	
Serum iron	→	Hip OA	1.18	2023	Ruan [54].	
Transferrin saturation	→	Hip OA	1.15		Ruan [54].	
Transferrin saturation	→	Knee OA	1.07	2022	Xu [55].	
	→	Hip OA	1.16			
	→	Hip/Knee OA	1.09			
Transferrin	→	Hip OA	0.92	2022	Xu [55].	
	→	Hip/Knee OA	0.95			
Folate	→	Overall OA	0.87	2023	Hong [50].	
Vitamin B12	→	Knee OA	0.95		Hong [50].	
Insulin-like growth factor−1 (IGF−1)	→	Hip OA	1.57	2021	Hartley [56].	
	→	Knee OA	1.30			
Serum copper	→	Overall OA	1.07	2021	Zhou [57].	
Serum zinc	→	Overall OA	1.18		Zhou [57].	
	→	Others OA	1.21			
Serum calcium	→	Overall OA	0.71	2021	Qu [58].	
	→	Hip OA	0.53			
	→	Knee OA	0.64			

Research has demonstrated a strong association between diseases such as thyroid disorders and gonadal dysfunction with the development of osteoarthritis [112, 113]. Twelve studies have identified potential causal links between 14 protein and hormone molecular biomarkers and the risk of osteoarthritis [48, 58–67, 78](Table 4). Eight markers were found to be associated with an increased risk of osteoarthritis, including serum testosterone, serum dihydrotestosterone, sex hormone-binding globulin, glycosylated hemoglobin (HbA1c), insulin-like growth factor-binding protein 4, lipocalin, leptin, and resistin. On the other hand, six markers were genetically predictive of causality and linked to a reduced risk of osteoarthritis, such as X-11,423-O-sulfo-L-tyrosine, ADpSGEGDFXAEGGGVR, parathyroid hormone, and retinol. Some studies provide further support for existing observational evidence. For instance, elevated levels of parathyroid hormone have been shown to be causally linked to a decreased risk of osteoarthritis [60]. Previous research has demonstrated that parathyroid hormone-related proteins inhibit the hypertrophic differentiation of chondrocytes, which is beneficial for repairing cartilage damage and osteoarthritis [114]. In addition, animal studies have confirmed that PTH slows the progression of cartilage degeneration in OA mice by reducing the number of mast cells in the subchondral bone and maintaining its microstructure [115]. Mendelian randomization analyses also support this genetic correlation, offering potential targets for future interventions.

The association between glycosylated hemoglobin (HbA1c) and insulin-like growth factor-binding protein 4 with an increased risk of osteoarthritis validates the link between diabetes and osteoarthritis risk [65, 66]. Potential mechanisms include local toxicity from high glucose exposure, increased expression of cytokines and protein hydrolases, and accumulation of advanced glycation end products (AGEs). Previous studies have reported that high glucose levels promote cartilage degeneration by increasing the expression of cyclooxygenase−2 (COX−2) and MMP−13, while decreasing the synthesis of type II collagen and peroxisome proliferator-activated receptor γ (PPARγ) [116]. Rasheed et al. further showed that AGEs induce IL−6 and IL−8 expression in human OA chondrocytes through the receptor for AGEs (RAGE) activation pathway, leading to oxidative stress [117]. We believe that the effects of hyperglycemia on OA are multifaceted due to its ability to induce a wide range of metabolic disorders.

MR reveals a causal relationship between adipokines, such as adipose transport proteins, leptin, and resistin, and the risk of osteoarthritis; however, the underlying mechanisms are more complex. Zhao et al. reported that high-dose leptin induces cell cycle arrest and senescence in chondrogenic progenitor cells through activation of the p53/p21 pathway and inhibition of the Sirt1 pathway, thereby promoting OA [118]. Moreover, Feng et al. reviewed the mechanisms of lipocalin’s effects on OA, suggesting that lipocalin may regulate chondrocyte autophagy and promote cellular pyroptosis in OA through multiple pathways [119]. On the other hand, it has been noted that while adipokines may trigger chondrocyte apoptosis, they primarily act as inflammatory mediators [120].

Table 4 Evidence from MR studies on protein, hormone molecules and osteoarthritis risk

Protein & hormone molecules	Causal direction	Osteoarthritis (OA)	OR	Years	Resources	
X−11,423–O-sulfo-L-tyrosine	→	Hand OA	0.44	2023	Gu [48].	
ADpSGEGDFXAEGGGVR	→	Hip OA	0.65		Gu [48].	
Parathyroid hormone	→	Knee OA	0.53	2021	Qu [59].	
Parathyroid hormone	→	Overall OA	0.73	2021	Huang [60].	
Serum retinol	→	Hip OA	0.44	2021	Qu [58].	
Testosterone (T)	→	Hip OA	1.56	2021	Yan [61].	
Dihydrotestosterone (DHT)	→	Hip OA	1.39		Yan [61].	
Sex-hormone-binding-globulin (SHBG)	→	Overall OA	1.09	2020	Qu [62].	
Alanine transaminase (ALT)	→	Hip OA	2.48	2023	Huang [63].	
	→	Knee OA	3.07		Huang [63].	
Retinol	→	Hip OA	0.45		Huang [64].	
Glycated hemoglobin (HbA1c)	→	Knee OA	1.56	2023	Chen [65].	
Insulin-like-growth factor-binding-protein4(IGFBP4)	→	Overall OA	1.48	2023	Han [66].	
	→	Knee OA	2.15			
Adiponectin	→	Knee OA	1.28	2021	Fan [67].	
Leptin	→	Knee OA	3.44		Fan [67].	
Resistin	→	Knee OA	1.18		Fan [67].	

Numerous studies have confirmed the presence of chronic low-grade inflammation in the progression of osteoarthritis [121]. Traditional observational studies have shown that elevated levels of systemic and local inflammation play a role in the progression of osteoarthritis. Additionally, abnormal peripheral inflammatory factors have been found to be somewhat predictive of the trajectory of osteoarthritis [122]. Two MR studies have demonstrated a causal link between genetically predicted levels of inflammatory factors and the risk of osteoarthritis [66, 78]. The expression of immune-related CD25-associated traits has been linked to a lower risk of osteoarthritis [69]. Additionally, lesser-known factors such as macrophage inflammatory protein−1β and tumor necrosis factor beta have also shown potential in reducing the risk of osteoarthritis [68](Table 5). By extrapolating the association between these genetically predicted inflammatory factors and osteoarthritis risk, we can gain a deeper understanding of the biological mechanisms underlying inflammation in osteoarthritis.

Table 5 Evidence from MR studies on immune, inflammatory markers and osteoarthritis risk

Immune & inflammatory markers	Causal direction	Osteoarthritis (OA)	OR	Years	Resources	
Macrophage-inflammatory protein−1beta (MIP−1β)	→	Overall OA	0.99	2023	Su [68].	
Tumour necrosis factor beta (TNF-β)	→	Overall OA	0.99		Su [68].	
C-C motif chemokine ligand 5(CCL5)	→	Overall OA	1.01		Su [68].	
Macrophage-colony-stimulating-factor (MCSF)	→	Knee OA	1.16	2023	Huang [78].	
Vascular-endothelial-growth-factor (VEGF)	→	Knee OA	1.09		Huang [78].	
CD25-related traits (7个)	→	Hip OA	0.8–0.9	2023	Luo [69].	
IgG4 Kappa(ig γ-4)	→	Overall OA	1.38	2023	Han [66].	
	→	Knee OA	1.89			

Other health factors

Due to the intricate pathogenesis of osteoarthritis, numerous MR studies have investigated potential connections between osteoarthritis and various health indicators such as childhood obesity, sarcopenia, body mass index, age at menstruation and childbearing, blood pressure, bone density, and gut flora [70–77](Table 6). The association between childhood obesity and adult health has been supported by numerous studies, including those focusing on osteoarthritis. A 25-year cohort study revealed a significant link between childhood overweight and knee pain, stiffness, and dysfunction in adulthood [123]. MR studies have confirmed a genetically predictable causal relationship between muscle loss or underweight and significant metabolic disturbances [70], which can lead to deterioration in general health. While the association with osteoarthritis has not received much attention [124], MR studies have found a significant causal link between genetically determined muscle loss and an increased risk of all osteoarthritis [71]. An abnormal rise in basal metabolism is often indicative of endocrine disruption or nutritional imbalance, a systemic alteration that has been associated with the risk for a variety of diseases [125]. Several previous MR studies have found a causal association between genetically predicted elevations in basal metabolic rate and osteoporosis and several cancers [126, 127]. Similarly, in osteoarthritis, MR studies have validated genetically predicted causal connections [73]. Further research is needed to understand the mechanisms and clinical implications of protective factors like age at menarche/first childbearing and gut flora in osteoarthritis [71, 77].

Interestingly, conflicting evidence was found in multiple MR studies regarding the relationship between bone mineral density (BMD) and osteoarthritis. Funck et al. reported a positive causal relationship between increased femoral neck BMD and increased risk of osteoarthritis, with each standard deviation increase in BMD increasing the risk of overall osteoarthritis, hip osteoarthritis, and knee osteoarthritis by 14%, 22%, and 18%, respectively [74]. Jiang et al. supported this finding by showing that genetically higher whole-body BMD increased the risk of hip osteoarthritis [76]. In addition, Liu et al. also noted that osteoporosis (decreased BMD) had a genetically predicted protective effect against osteoarthritis [42]. Some studies have proposed the hypothesis that increased bone density is associated with subchondral bone sclerosis and increased bone resorption [128, 129]. We are cautious about this hypothesis. In contrast, Qu et al. found that genetically reduced BMD in specific areas was associated with an increased risk of osteoarthritis [75]. The potential mechanistic explanation for this association is that bone loss in the subchondral bone in patients with OP leads to articular surface collapse and uneven articular cartilage stress, resulting in secondary osteophyte proliferation and cartilage damage [130]. Overall, the association between BMD and OA remains controversial. We believe that these conflicting results stem primarily from differences in the instrumental variables selected for MR studies.

Table 6 Evidence from MR studies on other health factors and osteoarthritis risk

Health factors	Causal direction	Osteoarthritis (OA)	OR	Years	Resources	
Childhood obesity	→	Overall OA	1.01	2022	Cao [70].	
	→	Hip OA	1.13			
	→	Knee OA	1.11			
Appendicular-lean-mass(ALM)	→	Hip OA	1.15	2023	Yang [71].	
	→	Knee OA	1.10			
Age at menarche(AAM)	→	Knee OA	0.86	2022	Wang [72].	
Age at first birth (AFB)	→	Overall OA	0.80		Wang [72].	
	→	Hip/Knee OA	0.79			
Basal metabolic rate (BMR)	→	Overall OA	1.01	2023	Zhou [73].	
	→	Hip OA	1.47			
	→	Knee OA	1.87			
Low systolic BP	→	Overall OA	1.55	2019	Funck [74].	
Body mass index(BMI)	→	Overall OA	1.57		Funck [74].	
	→	Hip OA	1.52			
	→	Knee OA	1.76			
High femoral neck BMD	→	Overall OA	1.14		Funck [74].	
	→	Hip OA	1.22			
	→	Knee OA	1.18			
Low femoral neck BMD	→	Hip OA	1.12	2023	Qu [75].	
	→	Knee OA	1.11			
Low lumber spine BMD	→	Overall OA	1.05		Qu [75].	
	→	Hip OA	1.16			
	→	Knee OA	1.11			
total body bone mineral density (TB-BMD)	→	Hip OA	1.20	2022	Jiang [76].	
Methanobacteriaceae family	→	Knee OA	0.93	2021	Yu [77].	
	→	Overall OA	0.95			
Desulfovibrionales order	→	Knee OA	0.88		Yu [77].	
Ruminiclostridium5 genus	→	Knee OA	0.85		Yu [77].	

Future research directions

Current MR analyses provide extensive evidence of OA risk, at least in a statistically significant manner. Regarding the need for additional MR studies, we believe that future research should focus on MR analyses that help develop treatment options for OA, such as drug-targeted MR.

Drug-targeted MR studies, an emerging research method, aim to evaluate whether changing exposure through therapeutic manipulation of a target can lead to expected outcomes [131–133]. In the field of osteoarthritis drug development, MR analysis is being used to investigate therapeutic mechanisms and identify specific targets. For instance, metformin, a well-known drug used for diabetes treatment, has shown protective effects against osteoarthritis [134, 135]. Research indicates that metformin may protect cartilage by targeting cells or activating specific receptors [136, 137]. Drug-targeted MR analyses have further confirmed that metformin targets AMP-activated protein kinase (AMPK) and growth differentiation factor 15 (GDF-15) have genetically predicted protective effects against osteoarthritis [138]. This strengthens the evidence for developing targeted therapies for osteoarthritis.

Combining MR with other methodologies, such as multi-omics analysis or MR-based multi-omics data analysis, can significantly improve result confidence. Additionally, given that most MR analyses are currently conducted using genetic data from European populations, there is a need to perform them in other ethnicities and subpopulations in the future to enhance result generalizability. Finally, causal associations revealed by MR should not solely rely on statistical significance but should be complemented with experimental studies to validate the functional roles of identified genetic variants and pathways in OA pathogenesis.

Limitations

However, we should be aware that MR analysis has its limitations in advancing disease research, particularly in reporting or interpreting MR results [139]. Common pitfalls include chain imbalance [13], horizontal pleiotropy [140], vertical pleiotropy [141], weak instrumental variables [142], and population stratification [143]. It is essential to carefully consider these shortcomings to ensure more accurate results when conducting or interpreting MR analyses. In addition, we should also note that observational studies have limitations that may deviate from real-world scenarios, even if the analysis process and interpretation of the results are fully compliant with norms. For example, in a drug-targeted MR analysis, the authors found a causal association between genetic variants in PCSK9 inhibitors and statins and the risk of cognitive impairment [144]. Ference et al. argued that the results of this study were unreliable in the real world, as PCSK9 monoclonal antibodies do not cross the blood-brain barrier, and also contradicted previous MR reports [145]. It is crucial to recognize that while observational studies can guide research direction and provide a broader perspective, statistically significant associations may not always align with actual outcomes.

Conclusion

In conclusion, MR analysis offers valuable insights into OA risk research. MR’s research model, based on genetic information, minimizes confounding factors and ethical concerns. In the exploration of OA risk, MR can efficiently and rapidly reveal potential associations and provide causal evidence. The application of drug-targeted MR further enhances the utility of MR analysis in OA therapeutic research, offering precise guidance for drug development. Looking ahead, there is a growing trend towards integrating MR with other methods, which can enhance result confidence. Additionally, adhering to rigorous research methodology and reporting standards is crucial for improving the quality and reliability of MR studies in the field of OA.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Acknowledgements

This study was supported by the Program for Youth Innovation in Future Medicine, Chongqing Medical University (no.w0155) and the Natural Science Foundation of Chongqing (no. 2023NSCQ-MSX0742).

Author contributions

X.L and S.Z provided direction and guidance throughout the preparation of this manuscript. Q.L and S.Z conducted the literature review, drafted. Q.Y, Y.D and H.Y helped a lot in the collection of materials and beautification of tables. All authors read and approved the final manuscript.

Data availability

No datasets were generated or analysed during the current study.

Declarations

Competing interests

The authors declare no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Qingfeng Luo and Shiyong Zhang contributed equally to this work.
==== Refs
References

1. He X Hu W Zhang Y Cellular senescence in skeletal disease: mechanisms and treatment Cell Mol Biol Lett 2023 28 1 88 10.1186/s11658-023-00501-5 37891477
He X, Hu W, Zhang Y et al (2023) Cellular senescence in skeletal disease: mechanisms and treatment. Cell Mol Biol Lett 28(1):8837891477 10.1186/s11658-023-00501-5
2. Rothrauff B Tang Q Wang J Osteoarthritis is positively associated with self-reported sleep trouble in older adults Aging Clin Exp Res 2022 34 11 2835 2843 10.1007/s40520-022-02225-6 36057081
Rothrauff B, Tang Q, Wang J et al (2022) Osteoarthritis is positively associated with self-reported sleep trouble in older adults. Aging Clin Exp Res 34(11):2835–284336057081 10.1007/s40520-022-02225-6
3. Global regional national burden of osteoarthritis 1990–2020 and projections to 2050: a systematic analysis for the global burden of Disease Study 2021 Lancet Rheumatol 2023 5 9 e508 e522 10.1016/S2665-9913(23)00163-7 37675071
Global regional, national burden of osteoarthritis (2023) 1990–2020 and projections to 2050: a systematic analysis for the global burden of Disease Study 2021. Lancet Rheumatol 5(9):e508–e52237675071 10.1016/S2665-9913(23)00163-7
4. Costăchescu B, Niculescu AG, Teleanu RI et al (2022) Recent advances in managing spinal intervertebral discs degeneration. Int J Mol Sci. 23 (12)
5. Clynes MA Harvey NC Curtis EM The epidemiology of osteoporosis Br Med Bull 2020 133 1 105 117 32282039
Clynes MA, Harvey NC, Curtis EM et al (2020) The epidemiology of osteoporosis. Br Med Bull 133(1):105–11732282039
6. Dong Y Kang H Peng R Global, Regional, and National Burden of Low Bone Mineral Density from 1990 to 2019: results from the global burden of Disease Study 2019 Front Endocrinol (Lausanne) 2022 13 870905 10.3389/fendo.2022.870905 35685212
Dong Y, Kang H, Peng R et al (2022) Global, Regional, and National Burden of Low Bone Mineral Density from 1990 to 2019: results from the global burden of Disease Study 2019. Front Endocrinol (Lausanne) 13:87090535685212 10.3389/fendo.2022.870905
7. Safiri S Kolahi AA Smith E Global, regional and national burden of osteoarthritis 1990–2017: a systematic analysis of the global burden of Disease Study 2017 Ann Rheum Dis 2020 79 6 819 828 10.1136/annrheumdis-2019-216515 32398285
Safiri S, Kolahi AA, Smith E et al (2020) Global, regional and national burden of osteoarthritis 1990–2017: a systematic analysis of the global burden of Disease Study 2017. Ann Rheum Dis 79(6):819–82832398285 10.1136/annrheumdis-2019-216515
8. Wang F Cai F Shi R Aging and age related stresses: a senescence mechanism of intervertebral disc degeneration Osteoarthritis Cartilage 2016 24 3 398 408 10.1016/j.joca.2015.09.019 26455958
Wang F, Cai F, Shi R et al (2016) Aging and age related stresses: a senescence mechanism of intervertebral disc degeneration. Osteoarthritis Cartilage 24(3):398–40826455958 10.1016/j.joca.2015.09.019
9. Ikegawa S The genetics of common degenerative skeletal disorders: osteoarthritis and degenerative disc disease Annu Rev Genomics Hum Genet 2013 14 245 256 10.1146/annurev-genom-091212-153427 24003854
Ikegawa S (2013) The genetics of common degenerative skeletal disorders: osteoarthritis and degenerative disc disease. Annu Rev Genomics Hum Genet 14:245–25624003854 10.1146/annurev-genom-091212-153427
10. D’Onofrio BM Sjölander A Lahey BB Accounting for confounding in Observational studies Annu Rev Clin Psychol 2020 16 25 48 10.1146/annurev-clinpsy-032816-045030 32384000
D’Onofrio BM, Sjölander A, Lahey BB et al (2020) Accounting for confounding in Observational studies. Annu Rev Clin Psychol 16:25–4832384000 10.1146/annurev-clinpsy-032816-045030
11. Harper S A future for Observational Epidemiology: clarity, credibility, transparency Am J Epidemiol 2019 188 5 840 845 10.1093/aje/kwy280 30877294
Harper S (2019) A future for Observational Epidemiology: clarity, credibility, transparency. Am J Epidemiol 188(5):840–84530877294 10.1093/aje/kwy280
12. Emdin CA Khera AV Kathiresan S Mendelian Randomization Jama 2017 318 19 1925 1926 10.1001/jama.2017.17219 29164242
Emdin CA, Khera AV, Kathiresan S (2017) Mendelian Randomization Jama 318(19):1925–192629164242 10.1001/jama.2017.17219
13. Lawlor DA Harbord RM Sterne JA Mendelian randomization: using genes as instruments for making causal inferences in epidemiology Stat Med 2008 27 8 1133 1163 10.1002/sim.3034 17886233
Lawlor DA, Harbord RM, Sterne JA et al (2008) Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27(8):1133–116317886233 10.1002/sim.3034
14. Smith GD Ebrahim S Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003 32 1 1 22 10.1093/ije/dyg070 12689998
Smith GD, Ebrahim S (2003) Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32(1):1–2212689998 10.1093/ije/dyg070
15. Haycock PC Burgess S Wade KH Best (but oft-forgotten) practices: the design, analysis, and interpretation of mendelian randomization studies Am J Clin Nutr 2016 103 4 965 978 10.3945/ajcn.115.118216 26961927
Haycock PC, Burgess S, Wade KH et al (2016) Best (but oft-forgotten) practices: the design, analysis, and interpretation of mendelian randomization studies. Am J Clin Nutr 103(4):965–97826961927 10.3945/ajcn.115.118216
16. Bovijn J Lindgren CM Holmes MV Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19 Lancet Rheumatol 2020 2 11 e658 e659 10.1016/S2665-9913(20)30345-3 33015641
Bovijn J, Lindgren CM, Holmes MV (2020) Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19. Lancet Rheumatol 2(11):e658–e65933015641 10.1016/S2665-9913(20)30345-3
17. Skrivankova VW Richmond RC Woolf BAR Strengthening the reporting of Observational studies in Epidemiology using mendelian randomization: the STROBE-MR Statement JAMA 2021 326 16 1614 1621 10.1001/jama.2021.18236 34698778
Skrivankova VW, Richmond RC, Woolf BAR et al (2021) Strengthening the reporting of Observational studies in Epidemiology using mendelian randomization: the STROBE-MR Statement. JAMA 326(16):1614–162134698778 10.1001/jama.2021.18236
18. Anderson EL Howe LD Wade KH Education, intelligence and Alzheimer’s disease: evidence from a multivariable two-sample mendelian randomization study Int J Epidemiol 2020 49 4 1163 1172 10.1093/ije/dyz280 32003800
Anderson EL, Howe LD, Wade KH et al (2020) Education, intelligence and Alzheimer’s disease: evidence from a multivariable two-sample mendelian randomization study. Int J Epidemiol 49(4):1163–117232003800 10.1093/ije/dyz280
19. Bottigliengo D Foco L Seibler P A mendelian randomization study investigating the causal role of inflammation on Parkinson’s disease Brain 2022 145 10 3444 3453 10.1093/brain/awac193 35656776
Bottigliengo D, Foco L, Seibler P et al (2022) A mendelian randomization study investigating the causal role of inflammation on Parkinson’s disease. Brain 145(10):3444–345335656776 10.1093/brain/awac193
20. Ho J Mak CCH Sharma V Mendelian randomization studies of lifestyle-related risk factors for Osteoarthritis: a PRISMA Review and Meta-Analysis Int J Mol Sci 2022 23 19 10.3390/ijms231911906
Ho J, Mak CCH, Sharma V et al (2022) Mendelian randomization studies of lifestyle-related risk factors for Osteoarthritis: a PRISMA Review and Meta-Analysis. Int J Mol Sci 23:1910.3390/ijms231911906
21. Davies NM, Holmes MV, Davey Smith G (2018) Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. Bmj. 362, k601
22. Pierce BL Ahsan H Vanderweele TJ Power and instrument strength requirements for mendelian randomization studies using multiple genetic variants Int J Epidemiol 2011 40 3 740 752 10.1093/ije/dyq151 20813862
Pierce BL, Ahsan H, Vanderweele TJ (2011) Power and instrument strength requirements for mendelian randomization studies using multiple genetic variants. Int J Epidemiol 40(3):740–75220813862 10.1093/ije/dyq151
23. Gala H Tomlinson I The use of mendelian randomisation to identify causal cancer risk factors: promise and limitations J Pathol 2020 250 5 541 554 10.1002/path.5421 32154591
Gala H, Tomlinson I (2020) The use of mendelian randomisation to identify causal cancer risk factors: promise and limitations. J Pathol 250(5):541–55432154591 10.1002/path.5421
24. Larsson SC Butterworth AS Burgess S Mendelian randomization for cardiovascular diseases: principles and applications Eur Heart J 2023 44 47 4913 4924 10.1093/eurheartj/ehad736 37935836
Larsson SC, Butterworth AS, Burgess S (2023) Mendelian randomization for cardiovascular diseases: principles and applications. Eur Heart J 44(47):4913–492437935836 10.1093/eurheartj/ehad736
25. Burgess S Davies NM Thompson SG Bias due to participant overlap in two-sample mendelian randomization Genet Epidemiol 2016 40 7 597 608 10.1002/gepi.21998 27625185
Burgess S, Davies NM, Thompson SG (2016) Bias due to participant overlap in two-sample mendelian randomization. Genet Epidemiol 40(7):597–60827625185 10.1002/gepi.21998
26. Burgess S Scott RA Timpson NJ Using published data in mendelian randomization: a blueprint for efficient identification of causal risk factors Eur J Epidemiol 2015 30 7 543 552 10.1007/s10654-015-0011-z 25773750
Burgess S, Scott RA, Timpson NJ et al (2015) Using published data in mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol 30(7):543–55225773750 10.1007/s10654-015-0011-z
27. Ni J Zhou W Cen H Evidence for causal effects of sleep disturbances on risk for osteoarthritis: a univariable and multivariable mendelian randomization study Osteoarthritis Cartilage 2022 30 3 443 450 10.1016/j.joca.2021.11.021 34890811
Ni J, Zhou W, Cen H et al (2022) Evidence for causal effects of sleep disturbances on risk for osteoarthritis: a univariable and multivariable mendelian randomization study. Osteoarthritis Cartilage 30(3):443–45034890811 10.1016/j.joca.2021.11.021
28. Li X Wang S Liu W Causal effect of physical activity and sedentary behaviors on the risk of osteoarthritis: a univariate and multivariate mendelian randomization study Sci Rep 2023 13 1 19410 10.1038/s41598-023-46984-2 37938609
Li X, Wang S, Liu W et al (2023) Causal effect of physical activity and sedentary behaviors on the risk of osteoarthritis: a univariate and multivariate mendelian randomization study. Sci Rep 13(1):1941037938609 10.1038/s41598-023-46984-2
29. Qiu P Wu J Kui L Causal effects of walking pace on osteoarthritis: a two-sample mendelian randomization study Front Genet 2023 14 1266158 10.3389/fgene.2023.1266158 37886687
Qiu P, Wu J, Kui L et al (2023) Causal effects of walking pace on osteoarthritis: a two-sample mendelian randomization study. Front Genet 14:126615837886687 10.3389/fgene.2023.1266158
30. Wang B Liu Y Zhang YC Assessment of causal effects of physical activity on the risk of osteoarthritis: a two-sample mendelian randomization study BMC Med Genomics 2023 16 1 237 10.1186/s12920-023-01681-x 37814247
Wang B, Liu Y, Zhang YC et al (2023) Assessment of causal effects of physical activity on the risk of osteoarthritis: a two-sample mendelian randomization study. BMC Med Genomics 16(1):23737814247 10.1186/s12920-023-01681-x
31. Cao Z Li Q Li Y Causal association of leisure sedentary behavior with arthritis: a mendelian randomization analysis Semin Arthritis Rheum 2023 59 152171 10.1016/j.semarthrit.2023.152171 36736025
Cao Z, Li Q, Li Y et al (2023) Causal association of leisure sedentary behavior with arthritis: a mendelian randomization analysis. Semin Arthritis Rheum 59:15217136736025 10.1016/j.semarthrit.2023.152171
32. Zhang Y Fan J Chen L Causal Association of Coffee Consumption and total, knee, hip and self-reported osteoarthritis: a mendelian randomization study Front Endocrinol (Lausanne) 2021 12 768529 10.3389/fendo.2021.768529 34858340
Zhang Y, Fan J, Chen L et al (2021) Causal Association of Coffee Consumption and total, knee, hip and self-reported osteoarthritis: a mendelian randomization study. Front Endocrinol (Lausanne) 12:76852934858340 10.3389/fendo.2021.768529
33. Li G Zhang Z Liu Y Genetically predicted tea intake increases the risk of osteoarthritis: a mendelian randomization study Front Genet 2022 13 1004392 10.3389/fgene.2022.1004392 36267411
Li G, Zhang Z, Liu Y (2022) Genetically predicted tea intake increases the risk of osteoarthritis: a mendelian randomization study. Front Genet 13:100439236267411 10.3389/fgene.2022.1004392
34. Wen MT Liang XZ Luo D Plasma lipids, alcohol intake frequency and risk of Osteoarthritis: a mendelian randomization study BMC Public Health 2023 23 1 1327 10.1186/s12889-023-16250-1 37434151
Wen MT, Liang XZ, Luo D et al (2023) Plasma lipids, alcohol intake frequency and risk of Osteoarthritis: a mendelian randomization study. BMC Public Health 23(1):132737434151 10.1186/s12889-023-16250-1
35. Ni J Wang P Yin KJ Does smoking protect against developing osteoarthritis? Evidence from a genetically informed perspective Semin Arthritis Rheum 2022 55 152013 10.1016/j.semarthrit.2022.152013 35500427
Ni J, Wang P, Yin KJ et al (2022) Does smoking protect against developing osteoarthritis? Evidence from a genetically informed perspective. Semin Arthritis Rheum 55:15201335500427 10.1016/j.semarthrit.2022.152013
36. Zhao H Zhu J Ju L Osteoarthritis & stroke: a bidirectional mendelian randomization study Osteoarthritis Cartilage 2022 30 10 1390 1397 10.1016/j.joca.2022.06.006 35798177
Zhao H, Zhu J, Ju L et al (2022) Osteoarthritis & stroke: a bidirectional mendelian randomization study. Osteoarthritis Cartilage 30(10):1390–139735798177 10.1016/j.joca.2022.06.006
37. Wang Z Kang C Xu P Osteoarthritis and cardiovascular disease: a mendelian randomization study Front Cardiovasc Med 2022 9 1025063 10.3389/fcvm.2022.1025063 36465459
Wang Z, Kang C, Xu P et al (2022) Osteoarthritis and cardiovascular disease: a mendelian randomization study. Front Cardiovasc Med 9:102506336465459 10.3389/fcvm.2022.1025063
38. Shen Y, Li F, Cao L et al (2022) Hip osteoarthritis and the risk of Lacunar Stroke: a two-sample mendelian randomization study. Genes (Basel). 13 (9)
39. Cai Y Zhang G Liang J Causal relationships between Osteoarthritis and Senile Central nerve system dysfunction: a bidirectional two-sample mendelian randomization study Front Aging Neurosci 2021 13 793023 10.3389/fnagi.2021.793023 35317304
Cai Y, Zhang G, Liang J et al (2021) Causal relationships between Osteoarthritis and Senile Central nerve system dysfunction: a bidirectional two-sample mendelian randomization study. Front Aging Neurosci 13:79302335317304 10.3389/fnagi.2021.793023
40. Xu H Ling Y Jiang H Osteoarthritis, coronary artery disease, and myocardial infarction: a mendelian randomization study Front Cardiovasc Med 2022 9 892742 10.3389/fcvm.2022.892742 36093168
Xu H, Ling Y, Jiang H et al (2022) Osteoarthritis, coronary artery disease, and myocardial infarction: a mendelian randomization study. Front Cardiovasc Med 9:89274236093168 10.3389/fcvm.2022.892742
41. Yin M Xu W Pang J Causal relationship between osteoarthritis with atrial fibrillation and coronary atherosclerosis: a bidirectional mendelian randomization study of European ancestry Front Cardiovasc Med 2023 10 1213672 10.3389/fcvm.2023.1213672 37583579
Yin M, Xu W, Pang J et al (2023) Causal relationship between osteoarthritis with atrial fibrillation and coronary atherosclerosis: a bidirectional mendelian randomization study of European ancestry. Front Cardiovasc Med 10:121367237583579 10.3389/fcvm.2023.1213672
42. Lin L Luo P Yang M Causal relationship between osteoporosis and osteoarthritis: a two-sample mendelian randomized study Front Endocrinol (Lausanne) 2022 13 1011246 10.3389/fendo.2022.1011246 36339427
Lin L, Luo P, Yang M et al (2022) Causal relationship between osteoporosis and osteoarthritis: a two-sample mendelian randomized study. Front Endocrinol (Lausanne) 13:101124636339427 10.3389/fendo.2022.1011246
43. Cui Z Feng H He B Type 2 diabetes and glycemic traits are not causal factors of Osteoarthritis: a two-sample mendelian randomization analysis Front Genet 2020 11 597876 10.3389/fgene.2020.597876 33519901
Cui Z, Feng H, He B et al (2020) Type 2 diabetes and glycemic traits are not causal factors of Osteoarthritis: a two-sample mendelian randomization analysis. Front Genet 11:59787633519901 10.3389/fgene.2020.597876
44. Xing X Wang Y Pan F Osteoarthritis and risk of type 2 diabetes: a two-sample mendelian randomization analysis J Diabetes 2023 15 11 987 993 10.1111/1753-0407.13451 37525375
Xing X, Wang Y, Pan F et al (2023) Osteoarthritis and risk of type 2 diabetes: a two-sample mendelian randomization analysis. J Diabetes 15(11):987–99337525375 10.1111/1753-0407.13451
45. Xu H Wei J Chen D Assessing causality between osteoarthritis and gastrointestinal disorders: a mendelian randomization study Sci Rep 2023 13 1 19603 10.1038/s41598-023-46767-9 37950016
Xu H, Wei J, Chen D et al (2023) Assessing causality between osteoarthritis and gastrointestinal disorders: a mendelian randomization study. Sci Rep 13(1):1960337950016 10.1038/s41598-023-46767-9
46. Zhang X, Wen Z, Xing Z et al (2023) The causal relationship between osteoarthritis and bladder cancer: a mendelian randomization study. Cancer Med. 13 (1)
47. Baker MC Robinson WH Ostrom Q Genetic association between atopic disease and osteoarthritis Osteoarthritis Cartilage 2023 32 2 220 225 10.1016/j.joca.2023.11.003 37951457
Baker MC, Robinson WH, Ostrom Q (2023) Genetic association between atopic disease and osteoarthritis. Osteoarthritis Cartilage 32(2):220–22537951457 10.1016/j.joca.2023.11.003
48. Gu Y Jin Q Hu J Causality of genetically determined metabolites and metabolic pathways on osteoarthritis: a two-sample mendelian randomization study J Transl Med 2023 21 1 357 10.1186/s12967-023-04165-9 37259122
Gu Y, Jin Q, Hu J et al (2023) Causality of genetically determined metabolites and metabolic pathways on osteoarthritis: a two-sample mendelian randomization study. J Transl Med 21(1):35737259122 10.1186/s12967-023-04165-9
49. Cui ZY Feng H He BC Causal associations between serum amino acid levels and osteoarthritis: a mendelian randomization study Osteoarthritis Cartilage 2023 31 8 1121 1131 10.1016/j.joca.2023.04.005 37088265
Cui ZY, Feng H, He BC et al (2023) Causal associations between serum amino acid levels and osteoarthritis: a mendelian randomization study. Osteoarthritis Cartilage 31(8):1121–113137088265 10.1016/j.joca.2023.04.005
50. Hong H, Chen L, Zhong Y et al (2023) Associations of Homocysteine, Folate, and Vitamin B12 with Osteoarthritis: A Mendelian Randomization Study. Nutrients. 15 (7)
51. Li X, Lu Z, Qi Y et al (2023) The Role of Polyunsaturated Fatty Acids in Osteoarthritis: Insights from a Mendelian Randomization Study. Nutrients. 15 (22)
52. Hindy G Åkesson KE Melander O Cardiometabolic Polygenic Risk scores and osteoarthritis outcomes: a mendelian randomization study using data from the Malmö Diet and Cancer Study and the UK Biobank Arthritis Rheumatol 2019 71 6 925 934 10.1002/art.40812 30615301
Hindy G, Åkesson KE, Melander O et al (2019) Cardiometabolic Polygenic Risk scores and osteoarthritis outcomes: a mendelian randomization study using data from the Malmö Diet and Cancer Study and the UK Biobank. Arthritis Rheumatol 71(6):925–93430615301 10.1002/art.40812
53. Meng H, Jiang L, Song Z et al (2022) Causal Associations of Circulating Lipids with Osteoarthritis: A Bidirectional Mendelian Randomization Study. Nutrients. 14 (7)
54. Ruan G Ying Y Lu S The effect of systemic iron status on osteoarthritis: a mendelian randomization study Front Genet 2023 14 1122955 10.3389/fgene.2023.1122955 37007954
Ruan G, Ying Y, Lu S et al (2023) The effect of systemic iron status on osteoarthritis: a mendelian randomization study. Front Genet 14:112295537007954 10.3389/fgene.2023.1122955
55. Xu J, Zhang S, Tian Y et al (2022) Genetic Causal Association between Iron Status and Osteoarthritis: A Two-Sample Mendelian Randomization. Nutrients. 14 (18)
56. Hartley A Sanderson E Paternoster L Mendelian randomization provides evidence for a causal effect of higher serum IGF-1 concentration on risk of hip and knee osteoarthritis Rheumatology (Oxford) 2021 60 4 1676 1686 10.1093/rheumatology/keaa597 33027520
Hartley A, Sanderson E, Paternoster L et al (2021) Mendelian randomization provides evidence for a causal effect of higher serum IGF-1 concentration on risk of hip and knee osteoarthritis. Rheumatology (Oxford) 60(4):1676–168633027520 10.1093/rheumatology/keaa597
57. Zhou J Liu C Sun Y Genetically predicted circulating levels of copper and zinc are associated with osteoarthritis but not with rheumatoid arthritis Osteoarthritis Cartilage 2021 29 7 1029 1035 10.1016/j.joca.2021.02.564 33640581
Zhou J, Liu C, Sun Y et al (2021) Genetically predicted circulating levels of copper and zinc are associated with osteoarthritis but not with rheumatoid arthritis. Osteoarthritis Cartilage 29(7):1029–103533640581 10.1016/j.joca.2021.02.564
58. Qu Z Yang F Hong J Causal relationship of serum nutritional factors with osteoarthritis: a mendelian randomization study Rheumatology (Oxford) 2021 60 5 2383 2390 10.1093/rheumatology/keaa622 33167034
Qu Z, Yang F, Hong J et al (2021) Causal relationship of serum nutritional factors with osteoarthritis: a mendelian randomization study. Rheumatology (Oxford) 60(5):2383–239033167034 10.1093/rheumatology/keaa622
59. Qu Z Yang F Yan Y A mendelian randomization study on the role of serum parathyroid hormone and 25-hydroxyvitamin D in osteoarthritis Osteoarthritis Cartilage 2021 29 9 1282 1290 10.1016/j.joca.2021.04.015 33975017
Qu Z, Yang F, Yan Y et al (2021) A mendelian randomization study on the role of serum parathyroid hormone and 25-hydroxyvitamin D in osteoarthritis. Osteoarthritis Cartilage 29(9):1282–129033975017 10.1016/j.joca.2021.04.015
60. Huang G Zhong Y Li W Causal relationship between parathyroid hormone and the risk of Osteoarthritis: a mendelian randomization study Front Genet 2021 12 686939 10.3389/fgene.2021.686939 34381493
Huang G, Zhong Y, Li W et al (2021) Causal relationship between parathyroid hormone and the risk of Osteoarthritis: a mendelian randomization study. Front Genet 12:68693934381493 10.3389/fgene.2021.686939
61. Yan YS Qu Z Yu DQ Sex steroids and osteoarthritis: a mendelian randomization study Front Endocrinol (Lausanne) 2021 12 683226 10.3389/fendo.2021.683226 34248845
Yan YS, Qu Z, Yu DQ et al (2021) Sex steroids and osteoarthritis: a mendelian randomization study. Front Endocrinol (Lausanne) 12:68322634248845 10.3389/fendo.2021.683226
62. Qu Z Huang J Yang F Sex hormone-binding globulin and arthritis: a mendelian randomization study Arthritis Res Ther 2020 22 1 118 10.1186/s13075-020-02202-2 32423484
Qu Z, Huang J, Yang F et al (2020) Sex hormone-binding globulin and arthritis: a mendelian randomization study. Arthritis Res Ther 22(1):11832423484 10.1186/s13075-020-02202-2
63. Huang G Li W Zhong Y Mendelian randomization to evaluate the causal relationship between liver enzymes and the risk of six specific bone and joint-related diseases Front Immunol 2023 14 1195553 10.3389/fimmu.2023.1195553 37662902
Huang G, Li W, Zhong Y et al (2023) Mendelian randomization to evaluate the causal relationship between liver enzymes and the risk of six specific bone and joint-related diseases. Front Immunol 14:119555337662902 10.3389/fimmu.2023.1195553
64. Huang L Xie Y Jin T Diet-derived circulating antioxidants and risk of knee osteoarthritis, hip osteoarthritis and rheumatoid arthritis: a two-sample mendelian randomization study Front Med (Lausanne) 2023 10 1147365 10.3389/fmed.2023.1147365 37415773
Huang L, Xie Y, Jin T et al (2023) Diet-derived circulating antioxidants and risk of knee osteoarthritis, hip osteoarthritis and rheumatoid arthritis: a two-sample mendelian randomization study. Front Med (Lausanne) 10:114736537415773 10.3389/fmed.2023.1147365
65. Chen L Jia C Yang H Causal effect of higher glycated hemoglobin (HbA1c) levels on knee osteoarthritis risk: a mendelian randomization study Rheumatol Ther 2023 10 1 239 247 36451030
Chen L, Jia C, Yang H (2023) Causal effect of higher glycated hemoglobin (HbA1c) levels on knee osteoarthritis risk: a mendelian randomization study. Rheumatol Ther 10(1):239–24736451030
66. Han BX Yan SS Yu H Causal effects of plasma proteome on osteoporosis and osteoarthritis Calcif Tissue Int 2023 112 3 350 358 10.1007/s00223-022-01049-w 36576504
Han BX, Yan SS, Yu H et al (2023) Causal effects of plasma proteome on osteoporosis and osteoarthritis. Calcif Tissue Int 112(3):350–35836576504 10.1007/s00223-022-01049-w
67. Fan J Zhu J Sun L Causal association of adipokines with osteoarthritis: a mendelian randomization study Rheumatology (Oxford) 2021 60 6 2808 2815 10.1093/rheumatology/keaa719 33221891
Fan J, Zhu J, Sun L et al (2021) Causal association of adipokines with osteoarthritis: a mendelian randomization study. Rheumatology (Oxford) 60(6):2808–281533221891 10.1093/rheumatology/keaa719
68. Su D Ai Y Zhu G Genetically predicted circulating levels of cytokines and the risk of osteoarthritis: a mendelian randomization study Front Genet 2023 14 1131198 10.3389/fgene.2023.1131198 36999058
Su D, Ai Y, Zhu G et al (2023) Genetically predicted circulating levels of cytokines and the risk of osteoarthritis: a mendelian randomization study. Front Genet 14:113119836999058 10.3389/fgene.2023.1131198
69. Luo H Zhu Y Guo B Causal relationships between CD25 on immune cells and hip osteoarthritis Front Immunol 2023 14 1247710 10.3389/fimmu.2023.1247710 37731506
Luo H, Zhu Y, Guo B et al (2023) Causal relationships between CD25 on immune cells and hip osteoarthritis. Front Immunol 14:124771037731506 10.3389/fimmu.2023.1247710
70. Cao Z Wu Y Li Q A causal relationship between childhood obesity and risk of osteoarthritis: results from a two-sample mendelian randomization analysis Ann Med 2022 54 1 1636 1645 10.1080/07853890.2022.2085883 35703935
Cao Z, Wu Y, Li Q et al (2022) A causal relationship between childhood obesity and risk of osteoarthritis: results from a two-sample mendelian randomization analysis. Ann Med 54(1):1636–164535703935 10.1080/07853890.2022.2085883
71. Yang J Liu P Wang S Causal relationship between Sarcopenia and osteoarthritis: a bi-directional two-sample mendelian randomized study Eur J Med Res 2023 28 1 327 10.1186/s40001-023-01322-0 37689698
Yang J, Liu P, Wang S et al (2023) Causal relationship between Sarcopenia and osteoarthritis: a bi-directional two-sample mendelian randomized study. Eur J Med Res 28(1):32737689698 10.1186/s40001-023-01322-0
72. Wang B Wu J Li H Using genetic instruments to estimate the causal effect of hormonal reproductive factors on osteoarthritis Front Public Health 2022 10 941067 10.3389/fpubh.2022.941067 36452961
Wang B, Wu J, Li H et al (2022) Using genetic instruments to estimate the causal effect of hormonal reproductive factors on osteoarthritis. Front Public Health 10:94106736452961 10.3389/fpubh.2022.941067
73. Zhou J Wei P Yi F The association between basal metabolic rate and osteoarthritis: a mendelian randomization study BMC Med Genomics 2023 16 1 258 10.1186/s12920-023-01704-7 37875874
Zhou J, Wei P, Yi F et al (2023) The association between basal metabolic rate and osteoarthritis: a mendelian randomization study. BMC Med Genomics 16(1):25837875874 10.1186/s12920-023-01704-7
74. Funck-Brentano T Nethander M Movérare-Skrtic S Causal factors for knee, hip, and Hand Osteoarthritis: a mendelian randomization study in the UK Biobank Arthritis Rheumatol 2019 71 10 1634 1641 10.1002/art.40928 31099188
Funck-Brentano T, Nethander M, Movérare-Skrtic S et al (2019) Causal factors for knee, hip, and Hand Osteoarthritis: a mendelian randomization study in the UK Biobank. Arthritis Rheumatol 71(10):1634–164131099188 10.1002/art.40928
75. Qu Y Chen S Han M Osteoporosis and osteoarthritis: a bi-directional mendelian randomization study Arthritis Res Ther 2023 25 1 242 10.1186/s13075-023-03213-5 38093316
Qu Y, Chen S, Han M et al (2023) Osteoporosis and osteoarthritis: a bi-directional mendelian randomization study. Arthritis Res Ther 25(1):24238093316 10.1186/s13075-023-03213-5
76. Jiang L Jiang Y Wang A The causal association between bone mineral density and risk of osteoarthritis: a mendelian randomization study Front Endocrinol (Lausanne) 2022 13 1021083 10.3389/fendo.2022.1021083 36714576
Jiang L, Jiang Y, Wang A et al (2022) The causal association between bone mineral density and risk of osteoarthritis: a mendelian randomization study. Front Endocrinol (Lausanne) 13:102108336714576 10.3389/fendo.2022.1021083
77. Yu XH Yang YQ Cao RR The causal role of gut microbiota in development of osteoarthritis Osteoarthritis Cartilage 2021 29 12 1741 1750 10.1016/j.joca.2021.08.003 34425228
Yu XH, Yang YQ, Cao RR et al (2021) The causal role of gut microbiota in development of osteoarthritis. Osteoarthritis Cartilage 29(12):1741–175034425228 10.1016/j.joca.2021.08.003
78. Huang G Li W Kan H Genetic influences of the effect of circulating inflammatory cytokines on osteoarthritis in humans Osteoarthritis Cartilage 2023 31 8 1047 1055 10.1016/j.joca.2022.12.007 36529415
Huang G, Li W, Kan H et al (2023) Genetic influences of the effect of circulating inflammatory cytokines on osteoarthritis in humans. Osteoarthritis Cartilage 31(8):1047–105536529415 10.1016/j.joca.2022.12.007
79. van de Luitgaarden IAT van Oort S Bouman EJ Alcohol consumption in relation to cardiovascular diseases and mortality: a systematic review of mendelian randomization studies Eur J Epidemiol 2022 37 7 655 669 10.1007/s10654-021-00799-5 34420153
van de Luitgaarden IAT, van Oort S, Bouman EJ et al (2022) Alcohol consumption in relation to cardiovascular diseases and mortality: a systematic review of mendelian randomization studies. Eur J Epidemiol 37(7):655–66934420153 10.1007/s10654-021-00799-5
80. Alhassan E Nguyen K Hochberg MC Causal factors for Osteoarthritis: a scoping review of mendelian randomization studies Arthritis Care Res (Hoboken) 2024 76 3 366 375 10.1002/acr.25252 37846209
Alhassan E, Nguyen K, Hochberg MC et al (2024) Causal factors for Osteoarthritis: a scoping review of mendelian randomization studies. Arthritis Care Res (Hoboken) 76(3):366–37537846209 10.1002/acr.25252
81. Berenbaum F Wallace IJ Lieberman DE Modern-day environmental factors in the pathogenesis of osteoarthritis Nat Rev Rheumatol 2018 14 11 674 681 10.1038/s41584-018-0073-x 30209413
Berenbaum F, Wallace IJ, Lieberman DE et al (2018) Modern-day environmental factors in the pathogenesis of osteoarthritis. Nat Rev Rheumatol 14(11):674–68130209413 10.1038/s41584-018-0073-x
82. Park HM, Kwon YJ, Kim HS et al (2019) Relationship between Sleep Duration and Osteoarthritis in Middle-aged and older women: a Nationwide Population-based study. J Clin Med. 8 (3)
83. Jacob L, Smith L, Konrad M et al (2021) Association between sleep disorders and osteoarthritis: a case-control study of 351,932 adults in the UK. J Sleep Res. 30 (6), e13367
84. Sang D, Lin K, Yang Y et al Prolonged sleep deprivation induces a cytokine-storm-like syndrome in mammals. Cell 2023, 186 (25), 5500–5516e5521
85. Jahanban-Esfahlan R Mehrzadi S Reiter RJ Melatonin in regulation of inflammatory pathways in rheumatoid arthritis and osteoarthritis: involvement of circadian clock genes Br J Pharmacol 2018 175 16 3230 3238 10.1111/bph.13898 28585236
Jahanban-Esfahlan R, Mehrzadi S, Reiter RJ et al (2018) Melatonin in regulation of inflammatory pathways in rheumatoid arthritis and osteoarthritis: involvement of circadian clock genes. Br J Pharmacol 175(16):3230–323828585236 10.1111/bph.13898
86. Hossain FM Hong Y Jin Y Physiological and pathological role of circadian hormones in Osteoarthritis: dose-dependent or Time-Dependent? J Clin Med 2019 8 9 10.3390/jcm8091415
Hossain FM, Hong Y, Jin Y et al (2019) Physiological and pathological role of circadian hormones in Osteoarthritis: dose-dependent or Time-Dependent? J Clin Med 8:910.3390/jcm8091415
87. Gates LS Perry TA Golightly YM Recreational physical activity and risk of incident knee osteoarthritis: an International Meta-Analysis of Individual participant-Level Data Arthritis Rheumatol 2022 74 4 612 622 10.1002/art.42001 34730279
Gates LS, Perry TA, Golightly YM et al (2022) Recreational physical activity and risk of incident knee osteoarthritis: an International Meta-Analysis of Individual participant-Level Data. Arthritis Rheumatol 74(4):612–62234730279 10.1002/art.42001
88. Lim CO, Park HJ, Koo BM et al (2022) Analysis of correlation between the consumption of beverages and the risk of radiographic knee osteoarthritis in Korean people: a cross-sectional study using the Fifth Korea National Health and Nutrition Examination Survey (KNHANES V-1, 2). Med (Baltim). 101 (37), e30105
89. Chen Y Zhang Y Zhang M Consumption of coffee and tea with all-cause and cause-specific mortality: a prospective cohort study BMC Med 2022 20 1 449 10.1186/s12916-022-02636-2 36397104
Chen Y, Zhang Y, Zhang M et al (2022) Consumption of coffee and tea with all-cause and cause-specific mortality: a prospective cohort study. BMC Med 20(1):44936397104 10.1186/s12916-022-02636-2
90. Chieng D Kistler PM Coffee and tea on cardiovascular disease (CVD) prevention Trends Cardiovasc Med 2022 32 7 399 405 10.1016/j.tcm.2021.08.004 34384881
Chieng D, Kistler PM (2022) Coffee and tea on cardiovascular disease (CVD) prevention. Trends Cardiovasc Med 32(7):399–40534384881 10.1016/j.tcm.2021.08.004
91. Zhang S, Wu S, Xia B et al (2024) Association of coffee and tea consumption with osteoporosis risk: A prospective study from the UK biobank. Bone. 117135
92. Guillan-Fresco M, Franco-Trepat E, Alonso-Perez A et al (2020) Caffeine, a risk factor for Osteoarthritis and Longitudinal Bone Growth Inhibition. J Clin Med. 9 (4)
93. Choi H Choi Y Kim J Longitudinal bone growth is impaired by direct involvement of caffeine with chondrocyte differentiation in the growth plate J Anat 2017 230 1 117 127 10.1111/joa.12530 27484046
Choi H, Choi Y, Kim J et al (2017) Longitudinal bone growth is impaired by direct involvement of caffeine with chondrocyte differentiation in the growth plate. J Anat 230(1):117–12727484046 10.1111/joa.12530
94. Kuo CL Liu ST Chang YL Zac1 regulates IL-11 expression in osteoarthritis Oncotarget 2018 9 65 32478 32495 10.18632/oncotarget.25980 30197757
Kuo CL, Liu ST, Chang YL et al (2018) Zac1 regulates IL-11 expression in osteoarthritis. Oncotarget 9(65):32478–3249530197757 10.18632/oncotarget.25980
95. Kadam UT Croft PR Clinical comorbidity in osteoarthritis: associations with physical function in older patients in family practice J Rheumatol 2007 34 9 1899 1904 17659751
Kadam UT, Croft PR (2007) Clinical comorbidity in osteoarthritis: associations with physical function in older patients in family practice. J Rheumatol 34(9):1899–190417659751
96. King LK Osteoarthritis and comorbidity: time for action Osteoarthritis Cartilage 2023 31 4 423 424 10.1016/j.joca.2023.01.007 36693559
King LK (2023) Osteoarthritis and comorbidity: time for action. Osteoarthritis Cartilage 31(4):423–42436693559 10.1016/j.joca.2023.01.007
97. Swain S Sarmanova A Coupland C Comorbidities in Osteoarthritis: a systematic review and Meta-analysis of Observational studies Arthritis Care Res (Hoboken) 2020 72 7 991 1000 10.1002/acr.24008 31207113
Swain S, Sarmanova A, Coupland C et al (2020) Comorbidities in Osteoarthritis: a systematic review and Meta-analysis of Observational studies. Arthritis Care Res (Hoboken) 72(7):991–100031207113 10.1002/acr.24008
98. Jacob L Tanislav C Kostev K Osteoarthritis and incidence of stroke and transient ischemic attack in 320,136 adults followed in general practices in the United Kingdom Joint Bone Spine 2021 88 2 105104 10.1016/j.jbspin.2020.105104 33166731
Jacob L, Tanislav C, Kostev K (2021) Osteoarthritis and incidence of stroke and transient ischemic attack in 320,136 adults followed in general practices in the United Kingdom. Joint Bone Spine 88(2):10510433166731 10.1016/j.jbspin.2020.105104
99. Booth FW Roberts CK Laye MJ Lack of exercise is a major cause of chronic diseases Compr Physiol 2012 2 2 1143 1211 10.1002/cphy.c110025 23798298
Booth FW, Roberts CK, Laye MJ (2012) Lack of exercise is a major cause of chronic diseases. Compr Physiol 2(2):1143–121123798298 10.1002/cphy.c110025
100. Arruda AL Hartley A Katsoula G Genetic underpinning of the comorbidity between type 2 diabetes and osteoarthritis Am J Hum Genet 2023 110 8 1304 1318 10.1016/j.ajhg.2023.06.010 37433298
Arruda AL, Hartley A, Katsoula G et al (2023) Genetic underpinning of the comorbidity between type 2 diabetes and osteoarthritis. Am J Hum Genet 110(8):1304–131837433298 10.1016/j.ajhg.2023.06.010
101. Jansen NEJ, Molendijk E, Schiphof D et al (2023) Metabolic syndrome and the progression of knee osteoarthritis on MRI. Osteoarthritis Cartilage
102. Kluzek S Newton JL Arden NK Is osteoarthritis a metabolic disorder? Br Med Bull 2015 115 1 111 121 10.1093/bmb/ldv028 26179188
Kluzek S, Newton JL, Arden NK (2015) Is osteoarthritis a metabolic disorder? Br Med Bull 115(1):111–12126179188 10.1093/bmb/ldv028
103. Zhang S Wang D Zhao J Metabolic syndrome increases osteoarthritis risk: findings from the UK Biobank prospective cohort study BMC Public Health 2024 24 1 233 10.1186/s12889-024-17682-z 38243159
Zhang S, Wang D, Zhao J et al (2024) Metabolic syndrome increases osteoarthritis risk: findings from the UK Biobank prospective cohort study. BMC Public Health 24(1):23338243159 10.1186/s12889-024-17682-z
104. Valdes AM Metabolic syndrome and osteoarthritis pain: common molecular mechanisms and potential therapeutic implications Osteoarthritis Cartilage 2020 28 1 7 9 10.1016/j.joca.2019.06.015 31408694
Valdes AM (2020) Metabolic syndrome and osteoarthritis pain: common molecular mechanisms and potential therapeutic implications. Osteoarthritis Cartilage 28(1):7–931408694 10.1016/j.joca.2019.06.015
105. Zhai G Clinical relevance of biochemical and metabolic changes in osteoarthritis Adv Clin Chem 2021 101 95 120 10.1016/bs.acc.2020.06.001 33706891
Zhai G (2021) Clinical relevance of biochemical and metabolic changes in osteoarthritis. Adv Clin Chem 101:95–12033706891 10.1016/bs.acc.2020.06.001
106. Zhang S Wang L Kang Y Nanomaterial-based reactive oxygen species scavengers for osteoarthritis therapy Acta Biomater 2023 162 1 19 10.1016/j.actbio.2023.03.030 36967052
Zhang S, Wang L, Kang Y et al (2023) Nanomaterial-based reactive oxygen species scavengers for osteoarthritis therapy. Acta Biomater 162:1–1936967052 10.1016/j.actbio.2023.03.030
107. Logters TT Laryea MD Jager M Kynurenine inhibits chondrocyte proliferation and is increased in synovial fluid of patients with septic arthritis J Orthop Res 2010 28 11 1490 1496 10.1002/jor.21158 20872586
Logters TT, Laryea MD, Jager M et al (2010) Kynurenine inhibits chondrocyte proliferation and is increased in synovial fluid of patients with septic arthritis. J Orthop Res 28(11):1490–149620872586 10.1002/jor.21158
108. Wang X Zhao Y Li S Activation of the kynurenine-aryl hydrocarbon receptor axis impairs the chondrogenic and chondroprotective effects of human umbilical cord-derived mesenchymal stromal cells in osteoarthritis rats Hum Cell 2023 36 1 163 177 10.1007/s13577-022-00811-4 36224488
Wang X, Zhao Y, Li S et al (2023) Activation of the kynurenine-aryl hydrocarbon receptor axis impairs the chondrogenic and chondroprotective effects of human umbilical cord-derived mesenchymal stromal cells in osteoarthritis rats. Hum Cell 36(1):163–17736224488 10.1007/s13577-022-00811-4
109. Bersch-Ferreira AC Sampaio GR Gehringer MO Association between polyunsaturated fatty acids and inflammatory markers in patients in secondary prevention of cardiovascular disease Nutrition 2017 37 30 36 10.1016/j.nut.2016.12.006 28359359
Bersch-Ferreira AC, Sampaio GR, Gehringer MO et al (2017) Association between polyunsaturated fatty acids and inflammatory markers in patients in secondary prevention of cardiovascular disease. Nutrition 37:30–3628359359 10.1016/j.nut.2016.12.006
110. Innes JK Calder PC Omega-6 fatty acids and inflammation Prostaglandins Leukot Essent Fat Acids 2018 132 41 48 10.1016/j.plefa.2018.03.004
Innes JK, Calder PC (2018) Omega-6 fatty acids and inflammation. Prostaglandins Leukot Essent Fat Acids 132:41–4810.1016/j.plefa.2018.03.004
111. de Seny D, Cobraiville G, Charlier E et al (2015) Apolipoprotein-A1 as a damage-associated molecular patterns protein in osteoarthritis: ex vivo and in vitro pro-inflammatory properties. PLoS ONE. 10 (4), e0122904
112. Chen S Sun X Zhou G Association between sensitivity to thyroid hormone indices and the risk of osteoarthritis: an NHANES study Eur J Med Res 2022 27 1 114 10.1186/s40001-022-00749-1 35820977
Chen S, Sun X, Zhou G et al (2022) Association between sensitivity to thyroid hormone indices and the risk of osteoarthritis: an NHANES study. Eur J Med Res 27(1):11435820977 10.1186/s40001-022-00749-1
113. Hussain SM Cicuttini FM Alyousef B Female hormonal factors and osteoarthritis of the knee, hip and hand: a narrative review Climacteric 2018 21 2 132 139 10.1080/13697137.2017.1421926 29378442
Hussain SM, Cicuttini FM, Alyousef B et al (2018) Female hormonal factors and osteoarthritis of the knee, hip and hand: a narrative review. Climacteric 21(2):132–13929378442 10.1080/13697137.2017.1421926
114. Zhang W Chen J Zhang S Inhibitory function of parathyroid hormone-related protein on chondrocyte hypertrophy: the implication for articular cartilage repair Arthritis Res Ther 2012 14 4 221 10.1186/ar4025 22971952
Zhang W, Chen J, Zhang S et al (2012) Inhibitory function of parathyroid hormone-related protein on chondrocyte hypertrophy: the implication for articular cartilage repair. Arthritis Res Ther 14(4):22122971952 10.1186/ar4025
115. Morita Y Ito H Ishikawa M Subchondral bone fragility with meniscal tear accelerates and parathyroid hormone decelerates articular cartilage degeneration in rat osteoarthritis model J Orthop Res 2018 36 7 1959 1968 10.1002/jor.23840 29251375
Morita Y, Ito H, Ishikawa M et al (2018) Subchondral bone fragility with meniscal tear accelerates and parathyroid hormone decelerates articular cartilage degeneration in rat osteoarthritis model. J Orthop Res 36(7):1959–196829251375 10.1002/jor.23840
116. Cannata F, Vadala G, Ambrosio L et al (2020) Osteoarthritis and type 2 diabetes: from pathogenetic factors to therapeutic intervention. Diabetes Metab Res Rev. 36 (3), e3254
117. Rasheed Z Akhtar N Haqqi TM Advanced glycation end products induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation end product-mediated activation of mitogen-activated protein kinases and nuclear factor-kappab in human osteoarthritis chondrocytes Rheumatology (Oxford) 2011 50 5 838 851 10.1093/rheumatology/keq380 21172926
Rasheed Z, Akhtar N, Haqqi TM (2011) Advanced glycation end products induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation end product-mediated activation of mitogen-activated protein kinases and nuclear factor-kappab in human osteoarthritis chondrocytes. Rheumatology (Oxford) 50(5):838–85121172926 10.1093/rheumatology/keq380
118. Zhao X, Dong Y, Zhang J et al (2016) Leptin changes differentiation fate and induces senescence in chondrogenic progenitor cells. Cell Death Dis. 7 (4), e2188
119. Feng X Xiao J Bai L Role of adiponectin in osteoarthritis Front Cell Dev Biol 2022 10 992764 10.3389/fcell.2022.992764 36158216
Feng X, Xiao J, Bai L (2022) Role of adiponectin in osteoarthritis. Front Cell Dev Biol 10:99276436158216 10.3389/fcell.2022.992764
120. Wang T He C Pro-inflammatory cytokines: the link between obesity and osteoarthritis Cytokine Growth Factor Rev 2018 44 38 50 10.1016/j.cytogfr.2018.10.002 30340925
Wang T, He C (2018) Pro-inflammatory cytokines: the link between obesity and osteoarthritis. Cytokine Growth Factor Rev 44:38–5030340925 10.1016/j.cytogfr.2018.10.002
121. Knights AJ Redding SJ Maerz T Inflammation in osteoarthritis: the latest progress and ongoing challenges Curr Opin Rheumatol 2023 35 2 128 134 10.1097/BOR.0000000000000923 36695054
Knights AJ, Redding SJ, Maerz T (2023) Inflammation in osteoarthritis: the latest progress and ongoing challenges. Curr Opin Rheumatol 35(2):128–13436695054 10.1097/BOR.0000000000000923
122. Pan F Tian J Cicuttini F Prospective Association between Inflammatory Markers and knee cartilage volume loss and Pain Trajectory Pain Ther 2022 11 1 107 119 10.1007/s40122-021-00341-1 34837639
Pan F, Tian J, Cicuttini F et al (2022) Prospective Association between Inflammatory Markers and knee cartilage volume loss and Pain Trajectory. Pain Ther 11(1):107–11934837639 10.1007/s40122-021-00341-1
123. Antony B Jones G Venn A Association between childhood overweight measures and adulthood knee pain, stiffness and dysfunction: a 25-year cohort study Ann Rheum Dis 2015 74 4 711 717 10.1136/annrheumdis-2013-204161 24347570
Antony B, Jones G, Venn A et al (2015) Association between childhood overweight measures and adulthood knee pain, stiffness and dysfunction: a 25-year cohort study. Ann Rheum Dis 74(4):711–71724347570 10.1136/annrheumdis-2013-204161
124. Biolo G Cederholm T Muscaritoli M Muscle contractile and metabolic dysfunction is a common feature of Sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia Clin Nutr 2014 33 5 737 748 10.1016/j.clnu.2014.03.007 24785098
Biolo G, Cederholm T, Muscaritoli M (2014) Muscle contractile and metabolic dysfunction is a common feature of Sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia. Clin Nutr 33(5):737–74824785098 10.1016/j.clnu.2014.03.007
125. Zheng L Zhang Z Sheng P The role of metabolism in chondrocyte dysfunction and the progression of osteoarthritis Ageing Res Rev 2021 66 101249 10.1016/j.arr.2020.101249 33383189
Zheng L, Zhang Z, Sheng P et al (2021) The role of metabolism in chondrocyte dysfunction and the progression of osteoarthritis. Ageing Res Rev 66:10124933383189 10.1016/j.arr.2020.101249
126. Wu E, Ni J, Tao L et al (2022) A bidirectional mendelian randomization study supports the causal effects of a high basal metabolic rate on colorectal cancer risk. PLoS ONE. 17 (8), e0273452
127. Hemani G, Tilling K, Davey Smith G (2017) Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 13 (11), e1007081
128. Hardcastle SA Gregson CL Deere KC High bone mass is associated with an increased prevalence of joint replacement: a case-control study Rheumatology (Oxford) 2013 52 6 1042 1051 10.1093/rheumatology/kes411 23362220
Hardcastle SA, Gregson CL, Deere KC et al (2013) High bone mass is associated with an increased prevalence of joint replacement: a case-control study. Rheumatology (Oxford) 52(6):1042–105123362220 10.1093/rheumatology/kes411
129. Hardcastle SA Dieppe P Gregson CL Osteophytes, enthesophytes, and high bone mass: a bone-forming triad with potential relevance in osteoarthritis Arthritis Rheumatol 2014 66 9 2429 2439 10.1002/art.38729 24910132
Hardcastle SA, Dieppe P, Gregson CL et al (2014) Osteophytes, enthesophytes, and high bone mass: a bone-forming triad with potential relevance in osteoarthritis. Arthritis Rheumatol 66(9):2429–243924910132 10.1002/art.38729
130. Lajeunesse D Reboul P Subchondral bone in osteoarthritis: a biologic link with articular cartilage leading to abnormal remodeling Curr Opin Rheumatol 2003 15 5 628 633 10.1097/00002281-200309000-00018 12960492
Lajeunesse D, Reboul P (2003) Subchondral bone in osteoarthritis: a biologic link with articular cartilage leading to abnormal remodeling. Curr Opin Rheumatol 15(5):628–63312960492 10.1097/00002281-200309000-00018
131. Georgakis MK Gill D Mendelian randomization studies in stroke: exploration of risk factors and drug targets with Human Genetic Data Stroke 2021 52 9 2992 3003 10.1161/STROKEAHA.120.032617 34399585
Georgakis MK, Gill D (2021) Mendelian randomization studies in stroke: exploration of risk factors and drug targets with Human Genetic Data. Stroke 52(9):2992–300334399585 10.1161/STROKEAHA.120.032617
132. Lin J Zhou J Xu Y Potential drug targets for multiple sclerosis identified through mendelian randomization analysis Brain 2023 146 8 3364 3372 10.1093/brain/awad070 36864689
Lin J, Zhou J, Xu Y (2023) Potential drug targets for multiple sclerosis identified through mendelian randomization analysis. Brain 146(8):3364–337236864689 10.1093/brain/awad070
133. Reay WR Cairns MJ Advancing the use of genome-wide association studies for drug repurposing Nat Rev Genet 2021 22 10 658 671 10.1038/s41576-021-00387-z 34302145
Reay WR, Cairns MJ (2021) Advancing the use of genome-wide association studies for drug repurposing. Nat Rev Genet 22(10):658–67134302145 10.1038/s41576-021-00387-z
134. Song Y Wu Z Zhao P The effects of metformin in the treatment of osteoarthritis: current perspectives Front Pharmacol 2022 13 952560 10.3389/fphar.2022.952560 36081941
Song Y, Wu Z, Zhao P (2022) The effects of metformin in the treatment of osteoarthritis: current perspectives. Front Pharmacol 13:95256036081941 10.3389/fphar.2022.952560
135. Baker MC, Sheth K, Liu Y et al (2023) Development of osteoarthritis in adults with type 2 diabetes treated with metformin vs a Sulfonylurea. JAMA Netw Open. 6 (3), e233646
136. Li J Zhang B Liu WX Metformin limits osteoarthritis development and progression through activation of AMPK signalling Ann Rheum Dis 2020 79 5 635 645 10.1136/annrheumdis-2019-216713 32156705
Li J, Zhang B, Liu WX et al (2020) Metformin limits osteoarthritis development and progression through activation of AMPK signalling. Ann Rheum Dis 79(5):635–64532156705 10.1136/annrheumdis-2019-216713
137. Li D Ruan G Zhang Y Metformin attenuates osteoarthritis by targeting chondrocytes, synovial macrophages and adipocytes Rheumatology (Oxford) 2023 62 4 1652 1661 10.1093/rheumatology/keac467 35984286
Li D, Ruan G, Zhang Y et al (2023) Metformin attenuates osteoarthritis by targeting chondrocytes, synovial macrophages and adipocytes. Rheumatology (Oxford) 62(4):1652–166135984286 10.1093/rheumatology/keac467
138. Zhang Y Li D Zhu Z Evaluating the impact of metformin targets on the risk of osteoarthritis: a mendelian randomization study Osteoarthritis Cartilage 2022 30 11 1506 1514 10.1016/j.joca.2022.06.010 35803489
Zhang Y, Li D, Zhu Z et al (2022) Evaluating the impact of metformin targets on the risk of osteoarthritis: a mendelian randomization study. Osteoarthritis Cartilage 30(11):1506–151435803489 10.1016/j.joca.2022.06.010
139. Davey Smith G Hemani G Mendelian randomization: genetic anchors for causal inference in epidemiological studies Hum Mol Genet 2014 23 R1 R89 98 10.1093/hmg/ddu328 25064373
Davey Smith G, Hemani G (2014) Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet 23(R1):R89–9825064373 10.1093/hmg/ddu328
140. Verbanck M Chen CY Neale B Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases Nat Genet 2018 50 5 693 698 10.1038/s41588-018-0099-7 29686387
Verbanck M, Chen CY, Neale B et al (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases. Nat Genet 50(5):693–69829686387 10.1038/s41588-018-0099-7
141. Wang Z Emmerich A Pillon NJ Genome-wide association analyses of physical activity and sedentary behavior provide insights into underlying mechanisms and roles in disease prevention Nat Genet 2022 54 9 1332 1344 10.1038/s41588-022-01165-1 36071172
Wang Z, Emmerich A, Pillon NJ et al (2022) Genome-wide association analyses of physical activity and sedentary behavior provide insights into underlying mechanisms and roles in disease prevention. Nat Genet 54(9):1332–134436071172 10.1038/s41588-022-01165-1
142. Burgess S Thompson SG Bias in causal estimates from mendelian randomization studies with weak instruments Stat Med 2011 30 11 1312 1323 10.1002/sim.4197 21432888
Burgess S, Thompson SG (2011) Bias in causal estimates from mendelian randomization studies with weak instruments. Stat Med 30(11):1312–132321432888 10.1002/sim.4197
143. Wacholder S Rothman N Caporaso N Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias J Natl Cancer Inst 2000 92 14 1151 1158 10.1093/jnci/92.14.1151 10904088
Wacholder S, Rothman N, Caporaso N (2000) Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J Natl Cancer Inst 92(14):1151–115810904088 10.1093/jnci/92.14.1151
144. Rosoff DB Bell AS Jung J Mendelian randomization study of PCSK9 and HMG-CoA reductase inhibition and cognitive function J Am Coll Cardiol 2022 80 7 653 662 10.1016/j.jacc.2022.05.041 35953131
Rosoff DB, Bell AS, Jung J et al (2022) Mendelian randomization study of PCSK9 and HMG-CoA reductase inhibition and cognitive function. J Am Coll Cardiol 80(7):653–66235953131 10.1016/j.jacc.2022.05.041
145. Ference BA Interpreting the clinical implications of drug-target mendelian randomization studies J Am Coll Cardiol 2022 80 7 663 665 10.1016/j.jacc.2022.06.007 35953132
Ference BA (2022) Interpreting the clinical implications of drug-target mendelian randomization studies. J Am Coll Cardiol 80(7):663–66535953132 10.1016/j.jacc.2022.06.007
